We are a global leader in delivering customer-centric solutions in the field of Antibody Drug Conjugates (ADCs) and other bioconjugates to global biopharmaceutical companies.

Our Unique Position

  • World leader in ADC contract development and manufacturing
  • World-class facilities in the UK and US, backed by a highly experienced team
  • Integrated services from conjugation development to clinical and commercial GMP batch manufacturing and sterile fill/finish
  • 98% GMP batch success rate
  • ADC Grangemouth Site is successfully audited by US FDA, UK MHRA, Brazil ANVISA, Japan PMDA

Antibody Drug Conjugation